Evidence map›Paper›PMID 24121212›Full record

ArticleBone marrow transplantation2014

Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.

J A Hol, T F W Wolfs, M B Bierings, C A Lindemans, A B J Versluys, A Wildt de, C E Gerhardt, J J Boelens

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score-weighted, retrospective assessment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Extended Dosing Regimens for Fungal Prophylaxis.Clinical microbiology reviews · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J A HolDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
T F W WolfsDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
M B BieringsDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
C A LindemansDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
A B J VersluysDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
A Wildt deDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
C E GerhardtDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
J J BoelensDepartment of Pediatric Blood and Marrow Transplantation, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
University Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was aimed at finding predictors of invasive fungal infection (IFI) after pediatric allogeneic hematopoietic SCT (HSCT). All children who received allogeneic HSCT in the Wilhelmina Children's Hospital Utrecht between 2004 and 2012 were included. HSCT data were prospectively collected. Patients were retrospectively classified into high- or low-risk groups for developing IFI using criteria based on available literature. Predictors for the occurrence of IFI were analyzed using Cox regression models. We used logistic regression models to analyze the association between other HSCT-related complications and IFI. Secondary outcomes were overall survival and treatment-related mortality (TRM). Two-hundred nine patients were included in the analysis; median age was 6.6 years. The cumulative incidence of IFI was 12%. In patients classified as 'low risk' (n=75), only 5.3% developed IFI (odds ratio (OR): 0.325; P=0.047). In multivariate analysis, a predictor for the occurrence of IFI was an a priori determined HSCT TRM risk >20% (based on EBMT-risk score). Post-HSCT, the administration of high-dose steroids was associated with IFI (OR: 4.458; P=0.010). Patients who developed IFI showed an increased risk of TRM (OR: 3.773; P=0.004). These results confirm that risk group stratification should guide intensity of monitoring for IFI and use of antifungal prophylaxis.

Indexed as

AdolescentAdultAmphotericin BAntifungal AgentsAspergillosisCandidiasisCaspofunginChildChild, PreschoolEchinocandinsFemaleFusariosisGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansInfantAmphotericin BAntifungal AgentsCaspofunginEchinocandinsLipopeptidesliposomal amphotericin BPyrimidinesTriazolesVoriconazole

Identifiers

PMID24121212
OpenAlexW2091633134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.